News &
Announcements

What does it take to manage the growing clinical and financial complexity of high-cost therapies?

ETS CEO Ashley Hume and SVP, Strategic Partnerships Chris Ford brought that conversation to the World 50 Accelerator Fall 2026 Employer Benefit Accelerator Roundtable, Oct. 1-2 in Dallas.

They shared the ETS perspective on preparing for the impact of specialty medications, transplants and cell and gene therapies, including how employers can identify risk earlier, support informed clinical decisions and manage costs more strategically.

For the first time since the event was known as the Employer Health Innovation Roundtable, more than 90 employer member companies will come together in one combined Roundtable focused on benefits innovation, cost management and strategic health care partnerships.